JAMA Oncology Journal Citation Rate 2026

ISSN 2374-2437 eISSN 2374-2445 American Medical Association US

Q1 Quartile Top Tier

About JAMA Oncology
{# Self-contained "answer block": one dense, LLM-quotable paragraph stating every core fact with an explicit as-of year, server-rendered and unique per journal. This is the canonical fact statement — other sections add narrative, they do not restate these numbers. #}

JAMA Oncology (JO) is a peer-reviewed academic journal, published by American Medical Association in US, catalogued under ISSN 2374-2437 (e-ISSN 2374-2445). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 7.40 (Q1 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model.

JAMA Oncology Citation Rate 2026 — In Context

JAMA Oncology has a 2025 2-Year Citation Rate (OpenAlex) of 7.40, placing it in the Q1 quartile. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.

JAMA Oncology operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view.

Researchers looking to publish in JAMA Oncology should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare JAMA Oncology against similar journals in the field, use our journal comparison tool.

ISSN (Print) 2374-2437
ISSN (Online) 2374-2445
Publisher American Medical Association
Country United States
APC / Cost Inquire with Publisher
In-depth profile & metrics

JAMA Oncology is published by American Medical Association and based in United States.

Its most recent citation rate stands at 7.398.

Links
Frequently Asked Questions about JAMA Oncology

JAMA Oncology does not hold a Clarivate (JCR) Impact Factor on JournalsHub. Its 2-year citation rate, computed from OpenAlex open citation data, is 7.398 — an open proxy for citation impact, not the licensed JCR Impact Factor.

No, JAMA Oncology is not an open access journal.

JAMA Oncology is published by American Medical Association.

JAMA Oncology is not currently listed in the major indexes we track (Scopus, DOAJ, Web of Science). This is not evidence of predatory practice — many legitimate new or regional journals are not yet indexed — but you should verify its peer-review process, editorial board, and indexing directly with the publisher before submitting.

The ISSN of JAMA Oncology is 2374-2437. Its electronic ISSN (eISSN) is 2374-2445.

JAMA Oncology sits in the Q1 quartile based on its latest impact factor of 7.40, ranked across all journals in our database.
Live Indexing Status
Updated March 2026

Track real-time indexing metrics to ensure this journal meets your academic requirements.

OpenAlex
Unverified
DOAJ
Non-OA
Predatory Check
Clean
Citation Rate
7.398
2-Year Citation Rate (OpenAlex) · 2025
Historical Trend
Initial data points only
Citation Rate by Year
Year Value Source
2025 7.398 2-Year Mean Citedness (OpenAlex)

Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.

Metadata

Last updated: Mar 15, 2026

Updated by: system

Get weekly updates

Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now
Compare 0 Open → Clear
Save your viewing history
You've browsed several journals this session. Sign in to track them in one place and get weekly impact-factor updates.
Save with Google